Leisl Packer

1.7k total citations
28 papers, 1.1k citations indexed

About

Leisl Packer is a scholar working on Molecular Biology, Oncology and Nutrition and Dietetics. According to data from OpenAlex, Leisl Packer has authored 28 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 6 papers in Oncology and 3 papers in Nutrition and Dietetics. Recurrent topics in Leisl Packer's work include Melanoma and MAPK Pathways (5 papers), Fibroblast Growth Factor Research (4 papers) and Cancer-related Molecular Pathways (3 papers). Leisl Packer is often cited by papers focused on Melanoma and MAPK Pathways (5 papers), Fibroblast Growth Factor Research (4 papers) and Cancer-related Molecular Pathways (3 papers). Leisl Packer collaborates with scholars based in Australia, United States and United Kingdom. Leisl Packer's co-authors include Richard Marais, Nicholas K. Hayward, Sandra Pavey, Robert Hayward, Mitchell Stark, Nelleke A. Gruis, Martine J. Jager, Wieke Zuidervaart, Berta Sanchez‐Laorden and Imanol Arozarena and has published in prestigious journals such as Cancer Cell, Cancer Research and Oncogene.

In The Last Decade

Leisl Packer

25 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leisl Packer Australia 16 815 333 163 155 147 28 1.1k
Kangmo Lu United States 19 965 1.2× 826 2.5× 78 0.5× 203 1.3× 67 0.5× 26 2.0k
Viktor Stránecký Czechia 18 642 0.8× 226 0.7× 43 0.3× 52 0.3× 177 1.2× 66 1.3k
Moyez Dharsee Canada 15 685 0.8× 256 0.8× 60 0.4× 74 0.5× 101 0.7× 21 1.0k
Pierre Scotney Australia 15 553 0.7× 168 0.5× 157 1.0× 66 0.4× 63 0.4× 21 1.0k
Sara Rezzola Italy 22 764 0.9× 128 0.4× 237 1.5× 647 4.2× 109 0.7× 42 1.5k
Véronique Gire France 20 1.2k 1.4× 607 1.8× 160 1.0× 23 0.1× 172 1.2× 31 1.8k
Andrea Fanjul United States 16 1.1k 1.4× 144 0.4× 224 1.4× 27 0.2× 66 0.4× 27 1.4k
George Lam United States 15 639 0.8× 159 0.5× 127 0.8× 18 0.1× 82 0.6× 22 1.0k
Jess M. Cunnick United States 19 899 1.1× 185 0.6× 330 2.0× 14 0.1× 145 1.0× 32 1.2k

Countries citing papers authored by Leisl Packer

Since Specialization
Citations

This map shows the geographic impact of Leisl Packer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leisl Packer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leisl Packer more than expected).

Fields of papers citing papers by Leisl Packer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leisl Packer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leisl Packer. The network helps show where Leisl Packer may publish in the future.

Co-authorship network of co-authors of Leisl Packer

This figure shows the co-authorship network connecting the top 25 collaborators of Leisl Packer. A scholar is included among the top collaborators of Leisl Packer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leisl Packer. Leisl Packer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Markman, Ben, Steven Kao, Nick Pavlakis, et al.. (2025). Durvalumab consolidation after chemoradiotherapy in unresectable stage III non–small cell lung cancer: A real-world experience from the Australian subset of PACIFIC-R. Cancer Treatment and Research Communications. 43. 100929–100929.
2.
Packer, Leisl, Vanessa Bonazzi, Robert J. Ju, et al.. (2017). PI3K Inhibitors Synergize with FGFR Inhibitors to Enhance Antitumor Responses in FGFR2mutant Endometrial Cancers. Molecular Cancer Therapeutics. 16(4). 637–648. 32 indexed citations
4.
Packer, Leisl, Sareena Rana, Robert Hayward, et al.. (2011). Nilotinib and MEK Inhibitors Induce Synthetic Lethality through Paradoxical Activation of RAF in Drug-Resistant Chronic Myeloid Leukemia. Cancer Cell. 20(6). 715–727. 97 indexed citations
5.
Arozarena, Imanol, Berta Sanchez‐Laorden, Leisl Packer, et al.. (2011). Oncogenic BRAF Induces Melanoma Cell Invasion by Downregulating the cGMP-Specific Phosphodiesterase PDE5A. Cancer Cell. 19(1). 45–57. 168 indexed citations
6.
Keizer, Peter L.J. de, Leisl Packer, Niels J. F. van den Broek, et al.. (2010). Activation of Forkhead Box O Transcription Factors by Oncogenic BRAF Promotes p21cip1-Dependent Senescence. Cancer Research. 70(21). 8526–8536. 74 indexed citations
7.
Packer, Leisl, Philip East, Jorge S. Reis‐Filho, & Richard Marais. (2009). Identification of direct transcriptional targets of V600EBRAF/MEK signalling in melanoma. Pigment Cell & Melanoma Research. 22(6). 785–798. 53 indexed citations
8.
Packer, Leisl, Sandra Pavey, Glen M. Boyle, et al.. (2007). Gene expression profiling in melanoma identifies novel downstream effectors of p14ARF. International Journal of Cancer. 121(4). 784–790. 17 indexed citations
9.
10.
Pavey, Sandra, Wieke Zuidervaart, Frans van Nieuwpoort, et al.. (2006). Increased p21-activated kinase-1 expression is associated with invasive potential in uveal melanoma. Melanoma Research. 16(4). 285–296. 24 indexed citations
11.
Zuidervaart, Wieke, Frans van Nieuwpoort, Mitchell Stark, et al.. (2005). Activation of the MAPK pathway is a common event in uveal melanomas although it rarely occurs through mutation of BRAF or RAS. British Journal of Cancer. 92(11). 2032–2038. 170 indexed citations
12.
Pavey, Sandra, Peter A. Johansson, Leisl Packer, et al.. (2004). Microarray expression profiling in melanoma reveals a BRAF mutation signature. Oncogene. 23(23). 4060–4067. 136 indexed citations
13.
Packer, Leisl, et al.. (2004). Expression of the cell surface mucin gene family in adenocarcinomas.. International Journal of Oncology. 25(4). 1119–1126. 53 indexed citations
14.
Obermair, Andreas, Bernd Schmid, Leisl Packer, et al.. (2002). Expression of MUC1 splice variants in benign and malignant ovarian tumours. International Journal of Cancer. 100(2). 166–171. 36 indexed citations
15.
Fuchs, Jürgen, Mauro Podda, Leisl Packer, & Robert A. Kaufmann. (2002). Morbidity risk in HFE associated hereditary hemochromatosis C282Y heterozygotes. Toxicology. 180(2). 169–181. 16 indexed citations
16.
Taylor, Allen, C. Kathleen Dorey, Thomas Nowell, Leisl Packer, & J. Fuchs. (1997). Oxidative stress and ascorbate in relation to risk for cataract and age-related maculopathy.. 231–264. 9 indexed citations
17.
Enstrom, James E., Leisl Packer, & J. Fuchs. (1997). Vitamin C in prospective epidemiological studies.. 381–398. 9 indexed citations
18.
Jariwalla, R J, et al.. (1997). Mechanisms underlying the action of vitamin C in viral and immunodeficiency disease.. 309–322. 2 indexed citations
19.
Packer, Leisl, et al.. (1997). Ascorbic acid and periodontal disease.. 505–516. 3 indexed citations
20.
Cutler, R. G., Leisl Packer, John F. Bertram, & A. Mori. (1995). Oxidative Stress and Aging. Birkhäuser Basel eBooks. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026